These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 4587065

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K, Lenzinger E, Hornik K, Schönbeck G, Hatzinger R, Langer G, Sieghart W, Aschauer HN.
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [Abstract] [Full Text] [Related]

  • 7. Trifluoperazine: a comparison between regular and high doses.
    Wijsenbeek H, Steiner M, Goldberg SC.
    Psychopharmacologia; 1974 Apr 08; 36(2):147-50. PubMed ID: 4601554
    [No Abstract] [Full Text] [Related]

  • 8. Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment.
    Levinson DF, Simpson GM, Singh H, Yadalam K, Jain A, Stephanos MJ, Silver P.
    Arch Gen Psychiatry; 1990 Aug 08; 47(8):761-8. PubMed ID: 2378547
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A, Okasha MS, Salih MA, Hirsch SR.
    Br J Psychiatry; 1979 Dec 08; 135():515-23. PubMed ID: 394794
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL.
    Curr Ther Res Clin Exp; 1974 Sep 08; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
    Warner AM, Wyman SM.
    Am J Psychiatry; 1975 Jul 08; 132(7):743-5. PubMed ID: 1137022
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
    Inderbitzin LB, Lewine RR, Scheller-Gilkey G, Swofford CD, Egan GJ, Gloersen BA, Vidanagama BP, Waternaux C.
    Am J Psychiatry; 1994 Dec 08; 151(12):1753-9. PubMed ID: 7977881
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May 08; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.